Thallia: Industrial scale microalgae

Thallia: Industrial scale microalgae

Unlike bacteria and yeast, microalgae have been relatively unexploited as a production system. Thallia Pharmaceuticals (formerly Heliosynthese) is exploiting more than 20 years of expertise in microalgae production to develop drugs and nutraceuticals.

Company founder Claude Gudin began working on microalgae in 1974 when he was at British Petroleum. Then in 1980, the Commissariat a l'Energie Atomique (France) started a program in bioenergy conversion based on the potential of microalgae as a source of energy. Over 10

Read the full 802 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE